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Abstract
Primate lentiviruses have evolved sophisticated strategies to suppress the immune response
of their host species. For example, HIV-2 and most simian immunodeficiency viruses (SIVs)
use their accessory protein Nef to prevent T cell activation and antiviral gene expression by
downmodulating the T cell receptor CD3. This Nef function was lost in HIV-1 and other vpu-
encoding viruses suggesting that the acquisition of Vpu-mediated NF-κB inhibition reduced
the selection pressure for inhibition of T cell activation by Nef. To obtain further insights into
the modulation of NF-κB activity by primate lentiviral accessory factors, we analyzed 32 Vpr
proteins from a large panel of divergent primate lentiviruses. We found that those of SIVcol
and SIVolc infecting Colobinae monkeys showed the highest efficacy in suppressing NF-κB
activation. Vpr-mediated inhibition of NF-κB resulted in decreased IFNβ promoter activity
and suppressed type I IFN induction in virally infected primary cells. Interestingly, SIVcol and
SIVolc differ from all other primate lentiviruses investigated by the lack of both, a vpu gene
and efficient Nef-mediated downmodulation of CD3. Thus, primate lentiviruses have evolved
at least three alternative strategies to inhibit NF-κB-dependent immune activation. Functional
analyses showed that the inhibitory activity of SIVolc and SIVcol Vprs is independent of
DCAF1 and the induction of cell cycle arrest. While both Vprs target the IKK complex or a fac-
tor further downstream in the NF-κB signaling cascade, only SIVolc Vpr stabilizes IκBα and
inhibits p65 phosphorylation. Notably, only de-novo synthesized but not virion-associated
Vpr suppressed the activation of NF-κB, thus enabling NF-κB-dependent initiation of viral
gene transcription during early stages of the replication cycle, while minimizing antiviral gene
expression at later stages. Our findings highlight the key role of NF-κB in antiviral immunity
and demonstrate that primate lentiviruses follow distinct evolutionary paths to modulate NF-
κB-dependent expression of viral and antiviral genes.
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Author summary
The cellular transcription factor NF-κB plays a complex role in the lentiviral replication
cycle. On the one hand, activation of NF-κB is required for efficient transcription of viral
genes and reactivation of latent proviruses. On the other hand, NF-κB is also a key driver
of antiviral gene expression, immune activation and progression to AIDS. As a result, pri-
mate lentiviruses tightly regulate the activation of NF-κB throughout their replication
cycle to enable transcription of viral genes while minimizing antiviral gene expression.
Here, we show that human and simian immunodeficiency viruses have evolved at least
three alternative strategies to suppress NF-κB-dependent immune activation: HIV-2 and
most SIVs prevent T cell activation via Nef-mediated downmodulation of CD3. In com-
parison, HIV-1 and its vpu-containing SIV precursors inhibit NF-κB activation via their
accessory protein Vpu and lost the CD3 downmodulation function of Nef. Finally, SIVcol
and SIVolc, infecting mantled guerezas and olive colobus monkeys, respectively, utilize
Vpr. Our findings emphasize the key role of NF-κB as inducer of antiretroviral immune
responses and add to the accumulating evidence that lentiviral accessory proteins target
innate signaling cascades by sophisticated mechanisms to evade restriction.
Introduction
Cells are equipped with a plethora of pattern recognition receptors (PRRs) that induce an anti-
viral immune response upon sensing of patterns associated with viral infection. Among them
are cytosolic receptors such as cGAS, PQBP1, IFI16, and RIG-I recognizing viral DNA or
RNA species, as well as restriction factors such as TRIM5α and Tetherin that sense viral cap-
sids or budding virions, respectively [1]. The signaling cascades initiated by these receptors
converge in the activation of a few key transcription factors (i.e. NF-κB, IRF3 and IRF7),
which induce the expression of interferons (IFNs) and other antiviral factors [1,2]. HIV and
related simian lentiviruses have evolved sophisticated means to evade these innate sensing
pathways. For example, reverse transcription of viral RNA mostly occurs before uncoating of
the viral capsid is completed [3]. Thus, viral RNA and DNA intermediates of reverse transcrip-
tion (RTIs) are cloaked by the viral capsid protein and cellular cofactors to prevent their recog-
nition by cytosolic PRRs [4]. However, primate lentiviruses do not only hide to evade
recognition by PRRs, but also directly target the signaling cascades that induce an antiviral
immune response. Especially the NF-κB pathway is tightly regulated since this transcription
factor plays a dual role in the retroviral replication cycle [5]. While NF-κB is essential for effi-
cient LTR-driven viral gene expression, it may also be detrimental to viral replication because
it induces the expression of cellular restriction factors and other antiviral genes. We have
recently shown that HIV-1 and related primate lentiviruses cope with this double-edged sword
by tight temporal regulation of NF-κB activity throughout the viral replication cycle [6]. Dur-
ing the early stage of infection, the accessory protein Nef boosts NF-κB activation to initiate
LTR-driven transcription of viral genes. A similar enhancing effect has been described for the
lentiviral envelope glycoprotein gp41 [7]. Once efficient and stable viral transcription is
ensured by the viral Tat protein, the late protein Vpu inhibits the activation of NF-κB in a
dominant manner to suppress expression of type I IFNs, restriction factors and other antiviral
genes [6]. This inhibitory effect on NF-κB is highly conserved among primate lentiviral Vpu
proteins [6,8], suggesting an important role in vivo. Notably, however, only HIV-1 and a few
closely related simian immunodeficiency viruses (SIVs) encode a vpu gene. HIV-2 and most
SIVs employ an alternative strategy and suppress T cell activation and consequently NF-κB
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activation and antiviral gene expression by Nef-mediated downmodulation of the T cell recep-
tor (TCR) CD3 from the cell surface [9–11]. This Nef function was lost in HIV-1 and its vpu-
containing SIV counterparts, i.e. SIVcpz, SIVgor, SIVgsn, SIVmus and SIVmon, infecting
chimpanzees, gorillas and greater spot-nosed, mustached and mona monkeys, respectively
[10]. The striking concordance between the presence of a vpu gene and loss of a specific Nef
function suggests that primate lentiviruses might use Nef-mediated downmodulation of CD3
or Vpu-dependent NF-κB inhibition as alternative strategies to suppress antiviral gene expres-
sion during late stages of the viral replication cycle [6,10,11]. One exception, however, has
been reported: SIVolc infecting olive colobus monkeys does not encode Vpu, but lost the CD3
downmodulation function of Nef [11]. Here, we examined how SIVolc might modulate NF-
κB activity and whether additional exceptions exist. We show that SIVcol from mantled guere-
zas also lacks both, a vpu gene and the ability to efficiently downmodulate CD3 via Nef. Com-
prehensive analyses of Vpr proteins from a large panel of diverse primate lentiviruses
demonstrated that those from SIVolc and SIVcol are most effective in inhibiting the activation
of NF-κB, thereby suppressing the induction of IFN expression. Thus, primate lentiviruses
evolved at least three alternative strategies (via Nef, Vpu or Vpr) to attenuate NF-κB-depen-
dent antiviral immune activation. Our results illustrate the enormous evolutionary flexibility
of lentiviral accessory proteins and corroborate the role of NF-κB as a key regulator of antire-
troviral immune responses.
Results
Nef proteins of SIVolc and SIVcol do not efficiently downmodulate the T
cell receptor CD3
Of more than 20 different SIV investigated, SIVolc from olive colobus monkeys (Procolobus
verus) is the only known vpu-deficient primate lentivirus that fails to downmodulate CD3 via
Nef [10,11]. All other vpu-deficient SIVs, including SIVwrc from Western red colobus mon-
keys (Piliocolobus badius badius), a close relative of SIVolc [12], use their Nef protein to sup-
press CD3-mediated T cell activation. To determine whether SIVolc is the only exception,
we analyzed the CD3 downmodulation activity of SIVcol from mantled guerezas (Colobus
guereza), whose Nef protein has not been fully characterized so far. SIVcol Nef caught our
attention as it fails to downmodulate CD4, but efficiently decreases CXCR4 surface levels,
thereby differing from all other lentiviral Nef proteins investigated [13]. Although SIVcol
and SIVolc infect Old World monkey species of the Colobinae subfamily, they are only dis-
tantly related [14].
CD3 downmodulation was analyzed in human peripheral blood mononuclear cells
(PBMCs) infected with HIV-1 NL4-3 IRES eGFP constructs encoding the nef alleles of SIVcol
isolates CGU1, CM243, and CM1437, SIVolc 97CI12, or SIVwrc 98CI04 (S1A Fig). HIV-1
NL4-3 and SIVmac239 Nefs served as controls. Flow cytometric analyses confirmed [11] that
Nef from SIVolc does not downmodulate CD3 (Fig 1A). Interestingly, a similar phenotype was
observed for the three SIVcol Nefs, which did not or only inefficiently decrease CD3 cell sur-
face levels in human cells. Notably, all Nef proteins were expressed and functional as they effi-
ciently increased virion infectivity by antagonizing the host restriction factor SERINC5 (Fig
1B) and decreased surface levels of CD28 and/or CXCR4 (S1B and S1C Fig). Since lentiviral
Nef proteins target the z chain of the TCR complex [15], we PCR-amplified and cloned the
CD3z chain of colobus monkeys to exclude that lack of activity in SIVcol and SIVolc Nefs is
due to species-specific differences in the target sequence. The intracellular domain of human
or colobus CD3z was fused to the extracellular domain of human CD8 to facilitate detection
by flow cytometry. While SIVwrc and SIVmac Nefs downmodulated the human and colobus
Modulation of NF-κB activation by lentiviral Vpr proteins
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006598 August 31, 2017 3 / 28
Fig 1. SIVcol and SIVolc Nef fail to efficiently downmodulate the T cell receptor CD3. (A) Human PBMCs were
transduced with VSV-G pseudotyped NL4-3 constructs coexpressing the indicated Nef proteins and eGFP via an IRES.
72 hr post-transduction, CD3 surface expression was quantified by flow cytometry. Mean values of six infections ± SEM
are shown on the left. The panel on the right shows examples for primary flow cytometry data. (B) Due to the lack of an
antibody detecting SIVcol and SIVolc Nef, counteraction of human SERINC5 was analyzed to verify functional Nef
expression. HEK293T cells were cotransfected with increasing amounts of a SERINC5 expression plasmid and the
NL4-3-based proviral constructs also used in (A). 40 hr post-transfection, infectious virus yield was quantified by
infection of TZM-bl reporter cells. Mean values of three independent experiments in triplicates ± SEM are shown. (C)
HEK293T cells were cotransfected with the proviral constructs described in (A) and expression vectors for CD3-CD8
fusion proteins comprising the cytoplasmic domain of human or colobus CD3ζ and the extracellular and
transmembrane domain of human CD8. 40 hr post transfection, CD3ζ downmodulation was determined by monitoring
CD8 surface levels via flow cytometry. Mean values of three to four independent experiments ± SEM are shown. In (A)
and (C), asterisks indicate statistically significant differences compared to the nef-defective control (**p < 0.01;
***p < 0.001).
https://doi.org/10.1371/journal.ppat.1006598.g001
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orthologs with similar efficiencies, SIVolc and SIVcol Nefs had no significant effects (Fig 1C,
S1D Fig). Thus, SIVolc and SIVcol lack efficient Nef-mediated suppression of T cell activation,
as well as Vpu-mediated inhibition of NF-κB activation, and it remained unclear whether/how
they might suppress NF-κB-dependent antiviral gene expression.
SIVolc and SIVcol Vpr suppress NF-κB activation
Besides Vpu and Nef, the accessory protein Vpr of the lab-adapted HIV-1 strains 89.6, NL4-3,
HxBru, and IIIB_LAI has been suggested to modulate the induction of NF-κB-dependent anti-
viral and proinflammatory gene expression [16–20]. To obtain more comprehensive insights
into the effect of Vpr on NF-κB signaling and immune activation, we examined a panel of 32
phylogenetically diverse vpr alleles representing all major lineages of HIV and SIV (i.e. HIV-1/
SIVcpz/SIVgor, HIV-2/SIVsmm/SIVmac, SIVgsn/mon/mus, SIVrcm, SIVsyk, SIVcol,
SIVwrc/SIVolc, SIVsab, and SIVlst) [12]. The deduced Vpr amino acid sequences varied con-
siderably in their lengths (83 to 138 amino acids) and showed limited sequence conservation
(S2A Fig). One exception was a highly conserved EAxxHF motif in the N-terminal α-helical
domain, known to be important for the induction of a G2 cell cycle arrest, nuclear localization
and virion-packaging of Vpr [21,22]. To determine the effect of these Vpr proteins on NF-κB
activity, we took advantage of a reporter vector expressing firefly luciferase under the control
of three NF-κB binding sites [6]. HEK293T cells were cotransfected with this reporter con-
struct, expression plasmids for Vpr, and an NF-κB-independent Gaussia luciferase vector to
normalize for cell viability and transfection efficiencies. In the absence of any stimulus, most
Vpr proteins increased NF-κB activity 2- to 50-fold, with those of SIVgsn, SIVmon and SIVlst
having the strongest effects (Fig 2, upper panel). In contrast, Vprs of SIVrcm, SIVcol and
SIVolc had no significant effect or even decreased NF-κB activity. While SIVrcm Vpr was
hardly detectable by Western blotting, inefficient expression or induction of cell death did not
explain the lack of NF-κB modulation by SIVcol and SIVolc Vprs (S2B and S2C Fig).
To further analyze how primate lentiviral Vpr proteins modulate NF-κB activation, we next
tested the effects of all Vprs in the presence of TNFα, a potent activator of NF-κB. Again, the
effects varied substantially between different Vpr proteins: those from HIV-1 THRO, SIVgsn,
SIVmon, SIVmus, SIVmac, SIVsab, and SIVlst enhanced NF-κB-driven reporter gene expres-
sion up to 5-fold, whereas SIVolc and SIVcol Vprs suppressed NF-κB activation by about
9-fold (Fig 2, middle panel). To investigate whether the effects of Vpr on NF-κB-mediated
gene expression are independent of the receptor, we repeated the experiment using a constitu-
tively active mutant of IKKβ for stimulation. This mutant induces the phosphorylation and
degradation of IκBα, the inhibitor of NF-κB, and allows clarifying whether active Vpr proteins
target the NF-κB pathway upstream or downstream of the IKK complex. While the impact of
lentiviral Vprs on NF-κB activity was again highly variable (Fig 2, bottom panel), the effects
correlated well with those observed upon stimulation with TNFα (S2D Fig). However, when
IKKβ instead of TNFα was used for stimulation, only SIVgsn Vpr significantly boosted NF-κB
activity. Most Vprs displayed modest suppressive effects, while those of SIVcol and SIVolc
were highly potent inhibitors (69–95% and 97% reduction, respectively). In line with the high
evolutionary conservation of the NF-κB signaling cascade [23], the potent inhibitory effects of
SIVcol and SIVolc Vpr were also observed in a simian cell line (S2E and S2F Fig).
To assess whether Vpu or Nef function affected the selection pressure for Vpr-mediated
modulation of NF-κB activity, we grouped the Vpr alleles according to the presence or absence
of a vpu gene and efficient Nef-mediated CD3 downmodulation activity in the respective
viruses (Fig 2, right panels). On average, Vpr proteins of lentiviruses expressing Vpu (HIV/
SIVvpu) or downmodulating CD3 (HIV/SIVCD3) inhibited NF-κB less efficiently than those of
Modulation of NF-κB activation by lentiviral Vpr proteins
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Fig 2. Modulation of NF-κB activity by primate lentiviral Vpr proteins. HEK293T cells were cotransfected with the indicated vpr
alleles, a firefly luciferase reporter construct under the control of three NF-κB binding sites, and a Gaussia luciferase construct for
normalization. In the middle and bottom panels, cells were additionally stimulated with TNFα or cotransfected with a constitutively
active mutant of IKKβ (c.a. IKKβ), respectively. Luciferase activities were determined 40 hr post-transfection. All values (including the
no inducer controls) are shown as percentage of the vector control, which was set to 100%. Mean values of three to ten independent
experiments in triplicates ± SEM are shown. Asterisks indicate statistically significant differences compared to the vector control
(*p<0.05; **p < 0.01; ***p < 0.001). In the panels on the right, Vprs were divided into three groups: Vprs from lentiviruses encoding
vpu (HIV/SIVvpu, green), downmodulating CD3 via Nef (HIV/SIVCD3, blue), or lacking a vpu gene and the CD3-downmodulation activity
(SIVolc/col, orange). Whiskers of the boxplots indicate the 5th and 95th percentiles.
https://doi.org/10.1371/journal.ppat.1006598.g002
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SIVolc/col, or even boosted the activation of this transcription factor. While inhibition of NF-
κB may confer a selection advantage as it suppresses antiviral gene expression, primate lentivi-
ruses also need to ensure efficient initiation of NF-κB-dependent viral gene expression. To
achieve this, most HIV/SIV strains use Nef and potentially gp41 to boost NF-κB activation
during early stages of the replication cycle [6,7]. Some viruses (e.g. SIVgsn, SIVmon), however,
lack the ability to enhance NF-κB activation via Nef and may use Vpr instead [6]. Thus, several
viral proteins seem to cooperate or compensate for each other in order to regulate the activa-
tion of NF-κB throughout the viral replication cycle. Another example is SIVsmm, which
induces only low levels of immune activation and apoptosis despite high levels of viremia in
infected sooty mangabeys [24]. While this virus prevents T cell activation via Nef-mediated
downmodulation of CD3, its Vpr protein also inhibited TNFα- and IKKβ-induced NF-κB acti-
vation, albeit to a lesser extent than SIVolc and SIVcol Vpr.
SIVolc and SIVcol Vpr prevent IFNβ promoter activation by inhibiting NF-
κB
To test whether Vpr-mediated modulation of NF-κB activity affects antiviral gene expression,
HEK293T cells were cotransfected with expression vectors for Vpr and a reporter construct
expressing firefly luciferase under the control of the IFNβ core promoter (Fig 3A). Cells were
stimulated with Sendai virus to activate both, NF-κB- and IRF3-mediated transcription [6,25].
Both pathways are evolutionarily highly conserved [23,26,27]. With the exception of a few
orthologs (e.g. those of SIVmon, SIVmus, SIVsab), most Vprs suppressed the activation of the
IFNβ promoter (S3 Fig). With a >10-fold reduction, SIVolc and SIVcol Vpr were the most
potent inhibitors. To determine whether this effect can be attributed to reduced NF-κB activ-
ity, the experiment was repeated using a mutant IFNβ promoter lacking the NF-κB binding
site (Fig 3A) [6]. Even in the absence of any NF-κB binding site, many Vprs moderately inhib-
ited luciferase reporter gene expression (S3 Fig), suggesting that NF-κB-independent and/or
unspecific inhibitory effects contribute to Vpr-mediated suppression of IFNβ induction. On
average, however, SIVolc and SIVcol Vprs suppressed IFNβ promoter activity substantially
more efficiently in the presence (7.3-fold) than in the absence (2.0-fold) of NF-κB binding
sites (Fig 3B). Thus, SIVcol and SIVolc Vpr proteins inhibit virus-induced IFN expression
mainly by interfering with NF-κB activation.
SIVolc Vpr suppresses immune activation in infected T cells
To analyze modulation of immune activation and IFNβ expression by Vpr in infected cells, we
inserted 13 vpr alleles with varying effects on NF-κB into the CH293 HIV-1 infectious molecu-
lar clone (IMC). We selected CH293 since it represents a primary strain of the most wide-
spread clade C of HIV-1 [28]. The vpr open reading frame in the vif-tat1 intergenic region of
HIV-1 M CH293 was replaced by restriction sites for XbaI and MluI, and heterologous
AU1-tagged vpr alleles were inserted to generate a derivative named CH293.1 (Fig 4A). Prema-
ture stop codons were inserted in the vpu gene to investigate whether some Vpr proteins may
compensate for the lack of Vpu-mediated NF-κB inhibition. In contrast, the nef and env open
reading frames were maintained as the respective gene products have been shown to boost
rather than suppress NF-κB activation [6,7]. All proviral constructs expressed their respective
heterologous Vpr protein (Fig 4B, lower panel) and (with the exception of HIV-2 20_56) all
Vprs were detected in purified viral particles (Fig 4B, upper panel). In some cases (e.g. HIV-2
20_56), exchange of vpr reduced Env expression and thus infectious virus yield (Fig 4B, S4A
Fig). This defect, however, could be rescued by pseudotyping the virions with the vesicular sto-
matitis virus glycoprotein (VSV-G) (S4A Fig). Unfortunately, however, the IMCs encoding
Modulation of NF-κB activation by lentiviral Vpr proteins
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SIVcol CGU1, CM243 and CM1437 vpr remained non-infectious, possibly due to the disrup-
tion of splice sites regulating Tat expression [29], and could therefore not be used for infection
studies.
All chimeric CH293 constructs were tested in transfected HEK293T cells to elucidate the
impact of Vpr on NF-κB activity if expressed in a proviral context, via the viral LTR promoter.
Here, the CH293.1 wild type virus induced the activation of NF-κB in the absence of any other
stimuli (Fig 4C). This activation was increased about 4-fold in the absence of intact vpu and
vpr genes. Lack of Vpu-mediated NF-κB inhibition was rescued by in cis expression of
SIVsmm, SIVcol and SIVolc Vpr (Fig 4C). In agreement with the results obtained using
expression vectors for Vpr (Fig 2), SIVgsn Vpr boosted the activation of NF-κB. To validate
these effects in infected T cells, we transduced SupD1 cells with VSV-G pseudotyped CH293.1
vpu- strains expressing the Vpr proteins of HIV-1 NL4-3, SIVgsn, SIVsmm, SIVolc or SIVwrc.
This T cell line is a derivative of SupT1 cells and expresses a short-lived firefly luciferase under
the control of an NF-κB promoter that allows monitoring of NF-κB activation over time [6].
In agreement with published data [6], vpu-defective HIV-1 CH293.1 constructs induced
higher levels of NF-κB activation than the parental virus (Fig 4D, S4B Fig). Lack of Vpu-medi-
ated NF-κB inhibition was rescued by SIVsmm and SIVolc (but not by HIV-1 and SIVwrc)
Vprs. Again, SIVgsn Vpr enhanced the activation of NF-κB. Notably, these differences in NF-
κB activity were not due to differences in infection rates (S4C Fig).
To test whether Vpr-mediated inhibition of NF-κB activation results in attenuated immune
activation in primary cells, we infected human PBMCs from three different donors with
CH293.1 wt or vpu- viruses expressing either no Vpr or the Vpr protein of HIV-1 NL4-3,
HIV-1 CH293, SIVolc or SIVwrc. At 72 hours post-infection, IFNβ expression levels were
quantified by qRT-PCR. In agreement with potent Vpu-mediated inhibition of NF-κB activa-
tion, CH293.1 wild type induced only low levels of IFNβ and deletion of vpu and vpr led to a 2-
Fig 3. Inhibition of IFNβ promoter activity by SIVcol and SIVolc Vpr. (A) Schematic representation of the canonical NF-κB signaling
pathway and the IFNβ promoter reporter constructs used in the present study. The wild type IFNβ core promoter contains an NF-κB binding
site that was mutated by introducing three nucleotide changes (highlighted in red). (B) HEK293T cells were cotransfected with different vpr
alleles, a Gaussia luciferase construct for normalization, and one of the firefly luciferase reporter constructs described in (A) (with wild type
or mutated NF-κB binding site). To activate the IFNβ promoter, cells were stimulated with Sendai virus. Luciferase activities were
determined 40 hr post-transfection. Vprs were categorized into three groups: Vprs from lentiviruses encoding vpu (HIV/SIVvpu, green),
downmodulating CD3 via Nef (HIV/SIVCD3, blue), or lacking a vpu gene and the CD3-downmodulation activity (SIVolc/col, orange)
(**p < 0.01; ***p < 0.001; n.s. p>0.05).
https://doi.org/10.1371/journal.ppat.1006598.g003
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Fig 4. Vpr-mediated modulation of NF-κB activity and immune activation in infected T cells. (A) Genomic organization of a chimeric
infectious molecular clone (IMC) of HIV-1 M CH293.1 expressing heterologous vpr alleles. The CH293 vpr open reading frame was replaced
by XbaI and MluI restriction sites (green), allowing the insertion of heterologous AU1-tagged vpr alleles (yellow). The original vpr start codon
in vif was silenced (blue) to prevent expression of a truncated CH293 Vpr. Expression of Vpu was abrogated by inserting a premature stop
codon (pink). (B) Expression of heterologous Vpr proteins from the CH293.1 chimeras described in (A). HEK293T cells were cotransfected
with CH293.1 IMCs encoding the indicated vpr alleles. 40 hr post-transfection, cells and supernatants were harvested and virions in the
supernatant were purified by centrifugation through a sucrose cushion. Subsequently, Western blotting was performed to detect AU1-tagged
Vpr, Env and Gag. Detection of GAPDH served as loading control. (C) HEK293T cells were cotransfected with the indicated CH293.1
chimeras, a firefly luciferase reporter construct under the control of three NF-κB binding sites, and a Gaussia luciferase construct for
normalization. Luciferase activities were determined 40 hr post-transfection. Mean values of three independent experiments in
triplicates ± SEM are shown. (D) The SupD1 NF-κB reporter cell line was transduced with the indicated VSV-G pseudotyped CH293.1
chimeras. Cells were harvested at various time points post-transduction to determine the activation levels of NF-κB. The mean values of
triplicate infections ± SD of a representative experiment are shown. (E) PBMCs of three different donors were transduced with VSV-G
pseudotyped CH293.1 chimeras encoding the indicated vpr alleles. Cells were harvested 72 hr post-transduction and total cellular RNA was
isolated and reversely transcribed. IFNβmRNA levels were determined by quantitative RT-PCR and normalized to GAPDH mRNA. The
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to 3-fold increase in IFNβ expression (Fig 4E). This immune activation was fully suppressed by
in cis complementation with Vpr of SIVolc, but not SIVwrc or HIV-1 Vprs (Fig 4E, S4D Fig).
Furthermore, SIVolc Vpr also inhibited induction of IFI44 expression, a typical ISG with pro-
posed anti-HIV-1 activity [30], which was upregulated in PBMCs infected with vpu-deficient
CH293.1 (S4E Fig). Higher IFNβ and IFI44 levels were not due to increased infection rates
(S4F Fig). Thus, SIVolc Vpr is a potent inhibitor of NF-κB-driven immune activation in
infected primary cells that can compensate for the lack of vpu.
SIVolc Vpr inhibits IκB degradation and reduces phosphorylation of p65
HIV-1 Vpr is well-known for its ability to induce a G2 cell cycle arrest, a process that involves
the recruitment of a DCAF1/DDB1/Cul4 E3 ligase complex and has been shown to mediate
escape from innate immunity [31]. To investigate whether the inhibition of NF-κB activation
by SIVolc and SIVcol Vpr depends on this activity, we infected Jurkat T cells with the chimeric
CH293.1 viruses and analyzed cell cycle progression by flow cytometry. While HIV-1 Vprs
inhibited the G2/M transition as expected, this was not the case for SIVolc Vpr (Fig 5A). Thus,
the ability of Vpr proteins to inhibit NF-κB activation did not correlate with the induction of
cell cycle arrest. In agreement with this finding, SIVcol and SIVolc efficiently suppressed the
activation of NF-κB upon knockdown of DCAF1 (S5A Fig).
To further elucidate the mechanisms underlying Vpr-mediated modulation of NF-κB acti-
vation, we directly compared the ability of SIVolc and SIVcol Vpr to inhibit NF-κB activation
upon TNFα stimulation or overexpression of the restriction factor Tetherin, a constitutively
active mutant of IKKβ, or p65/NF-κB itself. Dominant negative mutants of IKKβ and βTr-CP,
which prevent the degradation of IκB, served as controls. While SIVolc Vpr generally sup-
pressed NF-κB activity by>90%, SIVcol Vpr reduced Tetherin-induced signaling only by
about 30% (Fig 5B). These findings suggest that the distantly related SIVcol and SIVolc Vprs
have evolved different mechanisms to inhibit NF-κB-mediated immune activation. In accor-
dance with this, SIVolc, but not SIVcol stabilized IκB (Figs 5C and 3A, S5B Fig) and reduced
the activating phosphorylation of p65 at serine 529 (Figs 5D and 3A, S5C Fig) upon TNFα
stimulation. Thus, while both, SIVcol and SIVolc Vpr suppress NF-κB activation indepen-
dently of DCAF1 and the induction of a cell cycle arrest, only SIVolc Vpr prevents degradation
of IκB and phosphorylation of p65.
NF-κB inhibition reduces SIVolc and SIVcol LTR-driven gene expression
HIV-1 boosts NF-κB activation during early stages of its replication cycle to ensure efficient
LTR-driven expression of viral genes, while it suppresses activation of this transcription factors
during later stages to minimize cellular antiviral gene expression [6]. Similar to HIV-1 LTRs,
those of SIVolc and SIVcol contain putative NF-κB binding sites (S6A Fig). To analyze NF-κB
dependency, we amplified the LTR sequences of these simian viruses from cDNA of naturally
infected monkeys and generated firefly luciferase reporter constructs. Experiments in trans-
fected HEK293T cells revealed that these promoters are activated upon stimulation with TNFα
(Fig 6A) or a constitutively active mutant of IKKβ (Fig 6B), similarly to an HIV-1 LTR pro-
moter. LTR activity was suppressed by SIVolc and SIVcol Vpr (Fig 6A and 6B), and mutational
analyses showed that this inhibitory activity depends on the presence of NF-κB, but not Sp1
binding sites (S6B Fig). In summary, our results suggest that SIVolc and SIVcol may also
mean values ± SEM are shown. In (C) to (E), asterisks indicate statistically significant differences compared to CH293.1 wild type
transfected or infected cells (*p < 0.05; **p < 0.01; ***p < 0.001).
https://doi.org/10.1371/journal.ppat.1006598.g004
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Fig 5. Mechanisms of SIVolc and SIVcol Vpr-mediated inhibition of NF-κB activation. (A) Jurkat cells were
transduced with VSV-G pseudotyped chimeric CH293.1 viruses expressing the indicated vpr alleles. 48 hr post-
transduction, cell cycle progression was analyzed by propidium iodide staining and flow cytometry. Mean values of
three to four independent experiments ± SEM are shown on the left, examples of primary flow cytometry data are
shown on the right. Asterisks indicate statistically significant differences in the percentage of cells in the G2 phase
compared to the vector control (*p<0.05; **p < 0.01; ***p < 0.001). (B) HEK293T cells were transfected and
analyzed as described in Fig 2. Cells were stimulated by addition of TNFα or co-transfection of expression plasmids
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benefit from a temporal regulation of NF-κB activation that enables initiation of viral gene
expression during early stages while minimizing cellular antiviral gene expression during late
stages of the viral replication cycle.
De-novo expressed but not virion-associated SIVolc Vpr inhibits NF-κB
Vpr may act early and late on NF-κB activity because it is expressed during later stages of the
replication cycle, but also incorporated into viral particles. To determine whether virion-asso-
ciated and/or de-novo expressed Vpr accounts for the effect on NF-κB activity, HEK293T cells
were transfected either with HIV-1 CH293.1 vpu- chimeras expressing heterologous Vpr pro-
teins in cis or cotransfected with CH293.1 vpu- vpr- and an expression vector for Vpr in trans.
In the latter case, Vpr is incorporated into virions but not produced in newly infected cells.
Western blotting confirmed that most Vprs were efficiently incorporated (S7A Fig). Only
SIVwrc Vpr was hardly detectable in virions if provided in cis (S7A Fig, Fig 4B), and the results
obtained with this Vpr need to be interpreted with caution in this assay. The in cis or in trans
complemented viruses were used to infect SupD1 reporter cells, and NF-κB activity was
for Tetherin, c.a. IKKβ or p65. Dominant negative mutants (dom. neg.) of β-TrCP or IKKβ served as controls. Mean
values of three independent experiments in triplicates ± SEM are shown. (C) HEK293T cells were transfected with
plasmids coexpressing the indicated Vpr proteins and eGFP or a dominant-negative mutant of IKKβ. Cells were
stimulated 24 hr post-transfection with TNFα (10 ng/ml) or left untreated. 15 min after stimulation, cells were
harvested, fixed, and permeabilized and levels of IκBαwere analyzed by flow cytometry. (D) Levels of
phosphorylated p65 (Ser529) were determined by flow cytometry as described for (C). Mean values of three to six
independent experiments ± SEM are shown. In (B) to (D), asterisks indicate a statistically significant difference
compared to the vector control (*p<0.05; **p < 0.01; ***p < 0.001).
https://doi.org/10.1371/journal.ppat.1006598.g005
Fig 6. NF-κB inhibition by SIVolc and SIVcol Vpr reduces LTR-driven gene expression. (A, B) HEK293T cells
were cotransfected with the indicated vpr alleles, a firefly luciferase reporter construct under the control of the HIV-1
M, SIVcol or SIVolc LTR promoter, and a Gaussia luciferase construct for normalization. Cells were (A) stimulated
with TNFα or (B) cotransfected with a constitutively active mutant of IKKβ (c.a. IKKβ). Luciferase activities were
determined 40 hr post-transfection. Mean values of four independent experiments in triplicates ± SEM are shown
(*p<0.05; **p < 0.01; ***p < 0.001).
https://doi.org/10.1371/journal.ppat.1006598.g006
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monitored for 80 hours. Infections rates were controlled by flow cytometric analysis (S7B Fig).
Only vpu/vpr defective but not wild type HIV-1 CH293.1 induced the activation of NF-κB (Fig
7A, S7C Fig). Immune activation by CH293.1 vpu- vpr- could not be suppressed by in trans or
in cis complementation with CH293 or SIVwrc Vpr, confirming that these proteins do not
inhibit NF-κB activation (Fig 7A and 7B, S7C Fig). In contrast, expression of SIVolc Vpr in cis
but not in trans suppressed activation of NF-κB by vpu-deficient CH293.1 constructs (Fig 7C,
S7C Fig). Thus, only de-novo synthesized but not virion-associated SIVolc Vpr modulates the
activation of NF-κB in infected T cells. Similarly, SIVgsn Vpr boosted NF-κB activation in cis
but not in trans (Fig 7D, S7C Fig). Notably, the results were not biased by multiple rounds of
infection as treatment with the protease inhibitor Darunavir did not significantly affect induc-
tion of NF-κB activation upon HIV-1 infection or NF-κB inhibition by SIVolc Vpr, although
it efficiently blocked de novo generation of infectious HIV-1 particles (S7D–S7F Fig). Thus,
SIVolc Vpr will not interfere with efficient initiation of viral gene expression early after infec-
tion, since de novo synthesis of this viral protein is required to suppress the activation of NF-
κB in infected T cells.
Fig 7. Virion-associated Vpr does not affect the activation of NF-κB in infected T cells. (A-D) SupD1 cells were transduced with the
indicated VSV-G pseudotyped CH293.1 constructs. (A) HIV-1 CH293, (B) SIVwrc, (C) SIVolc, or (D) SIVgsn Vpr were either delivered in cis
(i.e. incorporated in viral particles AND encoded in the viral genome) or in trans (i.e. incorporated in viral particles, but not encoded in the
viral genome). CH293.1 wild type and CH293.1 vpu- vpr- served as controls. Cells were harvested at the indicated time points post-
transduction to determine the activation levels of NF-κB. The mean values of triplicate infections ± SD are shown. Asterisks indicate a
statistically significant difference compared to the mock control (*p<0.05; **p < 0.01; ***p < 0.001).
https://doi.org/10.1371/journal.ppat.1006598.g007
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Discussion
In this study, we show that primate lentiviruses use at least three alternative proteins (i.e. Nef,
Vpu or Vpr) to suppress NF-κB-mediated immune activation in infected cells. HIV-2 and the
majority of SIVs reduce T cell activation and NF-κB activation by Nef-mediated downmodula-
tion of CD3 [10,11]. However, this function was lost independently twice during lentiviral evo-
lution when the precursors of the SIVgsn/mon/mus and SIVcpz/gor/HIV-1 lineages acquired
a vpu gene (Fig 8, left panel). We have recently shown that Vpu proteins directly target the
canonical NF-κB signaling pathway and inhibit nuclear translocation of p65 to suppress
Fig 8. Vpu-, Vpr- and Nef-mediated inhibition of immune activation. The left panel illustrates the emergence of Vpu-, Vpr- and Nef-
mediated suppression of immune activation during primate lentiviral evolution: Most primate lentiviruses use their Nef proteins to prevent T
cell activation via downmodulation of CD3 (blue). HIV-1, SIVcpz/gor as well as SIVgsn/mon/mus encode a vpu gene and evolved Vpu-
mediated inhibition of NF-κB activation (green). Nef-mediated CD3 downmodulation was lost in these viruses (violet star). In SIVcol and
SIVolc, the loss of CD3 downmodulation by Nef is associated with the evolution of Vpr-mediated suppression of NF-κB signaling (orange).
The tree is a schematic representation of primate lentiviral evolution and based on previous phylogenetic analyses [12]; branch lengths do
not correlate with phylogenetic relationships. While Nef directly targets the CD3 receptor to prevent downstream NF-κB signaling, Vpu and
SIVcol/SIVolc Vpr target the canonical NF-κB signaling cascade further downstream, independently of the receptor (right panels). Some
Vpu proteins additionally counteract the host restriction factor Tetherin, which also acts as an immune sensor.
https://doi.org/10.1371/journal.ppat.1006598.g008
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expression of type I IFNs and other antiviral factors [6]. This function is highly conserved
among primate lentiviruses encoding vpu, suggesting that the evolution of Vpu-mediated NF-
κB inhibition has relieved the selection pressure for suppressing T cell activation by Nef. Here,
we demonstrate that SIVcol and SIVolc, which lack a vpu gene and fail to efficiently downmo-
dulate CD3 via Nef, evolved Vpr as potent inhibitor of NF-κB activity and consequently type I
IFN expression.
Our findings are another example for the enormous functional plasticity of lentiviral acces-
sory proteins and add to the accumulating evidence that these proteins often compensate for
each other or cooperate to accomplish the same goal. For example, a similar evolutionary tog-
gling between accessory viral proteins has been described for the counteraction of cellular
restriction factors: While HIV-2 and related SIV strains use Vpx to antagonize the host restric-
tion factor SAMHD1 in their respective host species, other primate lentiviruses achieve this by
using Vpr [32]. Similarly, primate lentiviruses switched several times between Vpu- and Nef-
mediated Tetherin antagonism before giving rise to HIV-1 [33]. Finally, three lentiviral pro-
teins (i.e. Nef, Vpu and Env) cooperate in the downmodulation of CD4 [13].
This enormous functional divergence of accessory proteins even from the same group or
lineage of HIV or SIV illustrates that results obtained with a single allele need to be interpreted
with great caution. Thus, although all SIVcol and SIVolc Vprs analyzed in this study efficiently
suppressed the activation of NF-κB, other isolates of these viruses may use yet another strategy
to minimize immune activation. In fact, the large differences in modulation of NF-κB activity
by HIV-1 Vpr proteins observed in the present study may explain why previous reports on the
role of Vpr in immune activation yielded contradictory results [16,19,20,34–43]. While several
groups reported reduced nuclear translocation of p65 and decreased secretion of IFNs in the
presence of Vpr [16,34–38], others observed no effect on nuclear translocation and DNA bind-
ing of this transcription factor [17], or even reported increased NF-κB-mediated immune acti-
vation [19,20,39–43]. Furthermore, modulation of NF-κB activity may not only depend on the
Vpr proteins analyzed but also on the stimulus used to activate NF-κB signaling. We therefore
examined several stimuli (TNFα, Tetherin, IKKβ, p65, Sendai virus) in various cell types from
different species (PBMCs, SupD1, HEK293T, COS-7). To better mimic the in vivo situation,
we generated chimeric HIV-1 constructs and monitored the effects of Vpr on NF-κB and
immune activation in virally infected human PBMCs. SIVolc and SIVcol Vpr potently sup-
pressed NF-κB activation under all experimental conditions. Flow cytometric analyses
revealed that SIVolc stabilizes IκBα upon TNFα stimulation. As expected, the stabilization of
this endogenous NF-κB inhibitor also prevented phosphorylation of p65 at serine 529 by
casein kinase II [44]. Notably, SIVcol Vpr seems to target different steps of the NF-κB signal-
ing cascade as it neither affected p65 phosphorylation nor IκBα degradation. Moreover, SIVcol
Vpr suppressed Tetherin-induced NF-κB activation by only 30%, while SIVolc Vpr inhibited
it by more than 90%.
It has been suggested that Vpr may suppress NF-κB activation by preventing the sensing of
reverse transcription intermediates (RTIs) [31]. Laguette and colleagues showed that HIV-1
Vpr induces the degradation of RTIs by recruitment of the SLX4-associated MUS81-EME1
endonucleases via DCAF1, a process that might also prevent G2/M cell cycle transition. A
more recent study, however, suggested that some Vpr proteins can induce a cell cycle arrest
also in the absence of SLX4 [45]. Here, we show that the ability of SIVcol and SIVolc Vpr to
suppress NF-κB activation is independent of the induction of a cell cycle arrest and the adaptor
protein DCAF1. In agreement with this, SIVcol and SIVolc Vpr inhibited NF-κB in both,
human and simian cells, although they fail to recruit the human SLX4 complex and do not
induce a cell cycle arrest in human cells [46].
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In our experiments, expression of HIV-1 Vpu and SIVolc Vpr resulted in a 2- to 3-fold
decrease in IFNβ mRNA levels in infected cells (Fig 4E). Although these differences may seem
low, it is very likely that the suppression of NF-κB activation by Vpu and/or Vpr confers a
selection advantage to the virus: First, the observation that Vpu-mediated NF-κB inhibition is
conserved among almost all lentiviruses encoding this accessory gene suggests that this activity
constitutes a significant fitness advantage. Second, NF-κB is a broad regulator of antiviral gene
expression, and its modulation will probably not only affect type I IFN production, but also a
variety of other antiviral proteins that cooperate in inhibiting viral replication. Finally, the
inhibitory effects determined by qRT-PCR may have been masked by uninfected bystander
cells and suppression of antiviral gene expression is presumably more pronounced within
infected cells. Global transcriptome analyses in combination with ex vivo or even in vivo repli-
cation kinetics will be necessary to decipher the overall effects of Vpu-/Vpr-mediated NF-κB
inhibition on cellular gene expression, viral replication and spread.
While it is not known whether Nef-mediated downmodulation of CD3 was lost before or
after the evolution of Vpr-mediated NF-κB inhibition, it is clear that both accessory proteins
target the NF-κB signaling cascade at different steps (Fig 8, right panels). By downmodulating
CD3, Nef specifically inhibits the very first step of the T cell receptor signaling pathway,
whereas SIVolc and SIVcol Vpr target the NF-κB signaling cascade further downstream and
may thus exert inhibitory activities on several pathways that culminate in the activation of NF-
κB. Although each viral particle contains about 275 Vpr molecules [47], inhibition of NF-κB
signaling requires the de-novo synthesis of SIVolc Vpr. Thus, Vpr (like Vpu) suppresses NF-
κB activity only during late stages of the viral replication cycle, thereby enabling the activation
of this transcription factor during early stages to initiate LTR-dependent viral gene expression.
As soon as the viral Tat protein ensures efficient viral gene expression, Vpr (or Vpu) inhibit
the activation of NF-κB to limit immune activation and antiviral gene expression.
In summary, our findings highlight the key role of NF-κB in antiviral immunity and show
that primate lentiviruses follow distinct evolutionary paths to balance NF-κB-dependent
expression of viral and antiviral genes. The present results improve our understanding of the
modulation of NF-κB-driven proinflammatory gene expression and thus shed light on the
establishment of viral latency and the pathophysiology of HIV infections, since chronic
immune activation is an important driver of the progression to AIDS. Finally, our data add to
the accumulating evidence that lentiviral accessory proteins do not only directly target restric-
tion factors to evade the immune system but also interfere with their expression by modulating
innate signaling cascades.
Materials and methods
Ethical statement
Experiments involving human peripheral blood mononuclear cells were reviewed and
approved by the Institutional Review Board (i.e. the Ethics Committee of Ulm University), and
individuals and/or their legal guardians provided written informed consent prior to donating
blood. All blood samples were anonymized before use. The use of established cell lines
(HEK293T, COS-7, TZM-bl and Jurkat cells) did not require the approval of the Institutional
Review Board. No non-human primates were involved, harmed, sampled or kept for this
study. cDNA of mantled guerezas (Colobus guereza) had been obtained from bushmeat sam-
ples of wild-caught animals in previous studies [48,49]. Similarly, the cDNA of a Peter’s Angola
colobus (Colobus angolensis palliatus) used in this study had been prepared before [50].
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Expression vectors
Primers flanking the nef (oligonucleotides P1, P2) and vpr (oligonucleotides (P11, P12) open
reading frame (ORF) were used to PCR-amplify the genes from cDNA of mantled guerezas
(Colobus guereza) infected with SIVcol CM243 or CM1437. PCR products from five indepen-
dent amplifications were sequenced to identify the most abundant sequence variant for subse-
quent cloning. SIVcol nef alleles were cloned via HpaI and MluI restriction sites into HIV-1
NL4-3-based proviral constructs coexpressing eGFP via an internal ribosome entry site (IRES)
[51] (oligonucleotides P3-P10). NL4-3 IRES eGFP reporter viruses containing SIVolc and
SIVwrc nef alleles have been described before [11]. SIVcol CM243 and CM1437 vpr alleles
were fused to an N-terminal AU-1 tag and cloned via XbaI and MluI restriction sites into bicis-
tronic pCG vectors coexpressing eGFP via an IRES (oligonucleotides P13, P14). All remaining
vpr alleles were either chemically synthesized or amplified from proviral constructs before
cloning into the pCG expression vector. Notably, N-terminal tagging was previously shown to
not affect Vpr function [31]. Human SERINC5 was expressed from PBJ6 (derived from PBJ5
by removing the SV40 origin of replication from the SV40-HTLV-1 hybrid promoter region)
expression vectors [52]. The coding sequence of colobus CD3z was amplified essentially as
described [50]. Total RNA from PBMCs of a Peter’s Angola colobus (Colobus angolensis pallia-
tus) was extracted using Qiagen RNeasy Plus Mini Kit and was used to prepare cDNA using
Transcriptor High Fidelity cDNA Synthesis Kit (Roche). Nested PCR was performed on
cDNA using Pfx Supermix (Life Technologies) and two primer pairs binding in untranslated
regions (oligonucleotides P15-P18). PCR products were sequenced and the resulting sequences
were assembled to build a reference coding sequence. The PCR products were subsequently
cloned into the pCR-BluntII-TOPO vector (Life Technologies). Five individual clones were
sequenced using M13 fw and M13 rev primers as well as two CD3z specific sequencing prim-
ers (oligonucleotides P19, P20). The intracellular domain of CD3z was fused to the extracellu-
lar and transmembrane domain of human CD8 (amino acids 1–205), and cloned into the
CMV-promoter based pCG expression vector via XbaI/MluI. Oligonucleotides P21 and P22
were used to PCR-amplify the 3’ LTR from cDNA of mantled guerezas infected with SIVcol
CM243. PCR products from five independent amplifications were sequenced to identify the
most abundant sequence variant for subsequent cloning. The SIVolc 97CI12 LTR sequence
was derived from the Los Alamos sequence database and synthesized (Baseclear). SIVcol
CM243 (oligonucleotides P23, P24) and SIVolc 97CI12 were cloned via MluI and XhoI restric-
tion sites into pGL3-enhancer vectors expressing firefly luciferase under the control of the
respective LTR. Please refer to S1, S2, S3 and S4 Tables in the supporting information files for
oligonucleotide sequences P1-P24.
HIV-1 CH293 proviral constructs
Generation of the infectious molecular clone (IMC) of the HIV-1 group M subtype C chronic
control virus CH293 has been described previously [28]. To monitor the ability of Vpr proteins
to modulate NF-κB activation during infection, we created a variant of CH293 allowing the
insertion of AU1-tagged vpr alleles from various HIV and SIV species via unique XbaI and
MluI restriction sites. This modified version was named CH293.1. The CH293 vpr open read-
ing frame (ORF) in the vif/tat1 intergenic region was replaced by XbaI and MluI restriction
sites and the following additional mutations were introduced using overlap extension PCR:
The vpr start codon in vif was mutated with a synonymous mutation in the vif ORF, so that the
Vif protein would remain unchanged and functional. Since the insertion of a new vpr gene
also introduces a second tat start codon, an additional base (cytosine) was introduced down-
stream of the MluI restriction site, prior to the original tat start codon. This creates a
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frameshift resulting in premature stop codons in all possible reading frames of the inserted sec-
ond tat start codon to avoid the expression of an additional Tat protein (oligonucleotides
P25-P28). Two additional XbaI restriction sites within the env sequence of CH293 were
mutated with synonymous mutations in the env ORF to facilitate cloning via XbaI/MluI (oli-
gonucleotides P29- P32). Finally, vpr alleles with N-terminal AU1 tag were excised from pCG
expression constructs and cloned into CH293.1 via the XbaI/MluI restriction sites. When indi-
cated, Vpu expression was disrupted by insertion of two stop codons downstream of the vpu
start codon using the QuikChange II XL site-directed mutagenesis kit (Agilent Technologies)
according to the manufacturer’s instructions (oligonucleotides P33, P34). Please refer to S5
Table of the supporting information files for oligonucleotide sequences P25-P34.
Cell culture
Human Embryonic Kidney (HEK) 293T cells and COS-7 cells (both obtained from the Ameri-
can Type Culture Collection (ATCC)) were first described by DuBridge et al. [53] and Gluz-
man [54], respectively. TZM-bl reporter cells (kindly provided by Drs. Kappes and Wu and
Tranzyme Inc. through the NIH AIDS Reagent Program [55]) were used to determine infec-
tious virus yield. All three cell lines were maintained in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% fetal calf serum (FCS), 2 mM glutamine, 100 μg/ml strepto-
mycin and 100 U/ml penicillin. Jurkat cells (obtained from the American Type Culture Collec-
tion (ATCC)) were generated by Schneider et al. [56] and cultivated in RPMI 1640 medium
supplemented with 10% FCS, 2 mM glutamine, streptomycin (100 μg/ml) and penicillin (100
U/ml). The SupD1 cell line (generated in our lab [6]) expresses a short-lived version of an NF-
κB-dependent firefly luciferase reporter. SupD1 cells were cultivated in RPMI 1640 medium
supplemented with 10% FCS, 2 mM glutamine, streptomycin (100 μg/ml), penicillin (100 U/
ml) and hygromycin B (200 μg/ml). Peripheral blood mononuclear cells (PBMCs) from
healthy human donors were isolated from buffy coats using lymphocyte separation medium
(Biocoll separating solution; Biochrom) and cultivated in RPMI 1640 medium supplemented
with 10% FCS, 2 mM glutamine, streptomycin (100 μg/ml), penicillin (100 U/ml), IL-2 (10 ng/
ml) (Miltenyi Biotec) and PHA (1 μg/ml) (Thermo Scientific).
NF-κB reporter assay in HEK293T and COS-7 cells
To determine the effect of Vpr on NF-κB activity, HEK293T cells were seeded in 96-well plates
coated with poly-L-lysine and transfected in triplicates using a standard calcium phosphate
transfection protocol [10]. COS-7 cells were seeded in non-coated 96-well plates and transfected
using polyethylenimine (PEI). Cells were cotransfected with a firefly luciferase reporter con-
struct under the control of three NF-κB binding sites (100 ng), a Gaussia luciferase construct
under the control of a constitutively active pTAL promoter (5 ng) for normalization, and
expression vectors for different Vpr proteins (100 ng) or CH293.1 proviral constructs express-
ing heterologous Vpr proteins (100 ng). To determine the influence of DCAF1 on modulation
of NF-κB activation by Vpr, DCAF1 was depleted by cotransfecting expression vectors for three
different shRNAs (50 ng) [57]. To activate NF-κB, Tetherin (40 ng), p65 (1.6 ng) or a constitu-
tively active mutant of IKKβ (40 ng) was cotransfected or cells were stimulated with TNFα (20
ng/ml) for 24 hr. 40 hr post-transfection, a dual luciferase assay was performed and the firefly
luciferase signals were normalized to the corresponding Gaussia luciferase control values.
IFNβ-promoter reporter assay in HEK293T cells
To determine the effect of Vpr proteins on IFNβ-promoter activity, dual luciferase assays were
performed as described above. Cells were transfected with firefly luciferase reporter constructs
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under the control of the wild type IFNβ-promoter (100 ng) or a mutant thereof lacking the
NF-κB binding site as previously described [6]. The promoter was activated by stimulation
with Sendai virus for 24 hr.
LTR reporter assay in HEK293T cells
To determine the effect of Vpr proteins on LTR activity, reporter constructs were generated in
which a firefly luciferase reporter gene is expressed under the control of the SIVcol CM243,
SIVolc 97CI12 and HIV-1 NL4-3 LTR, or mutants thereof with mutated NF-κB or Sp1 binding
sites. HEK293T cells were cotransfected with these constructs (100 ng), expression vectors for
different Vpr proteins (100 ng) and Gaussia luciferase vectors under the control of a constitu-
tively active pTAL promoter (5 ng) for normalization. LTR-mediated transcription was acti-
vated by cotransfection of a constitutively active mutant of IKKβ (40 ng), Sp1 (40 ng) or by
stimulation with TNFα (20 ng/ml). 40 hr post-transfection, a dual luciferase assay was per-
formed and the firefly luciferase signals were normalized to the corresponding Gaussia lucifer-
ase control values.
Virus production
To generate virus stocks, HEK293T cells were transfected in 6-well plates with proviral HIV-1
constructs (5 μg) using a standard calcium phosphate transfection protocol [10]. For the pro-
duction of VSV-G pseudotyped HIV-1 particles, the proviral constructs were cotransfected
with expression plasmids for VSV-G (1 μg). For mock infection controls, HEK293T cells were
treated with transfection reagents only. Supernatants were harvested 40 hr post-transfection.
Infectivity assay
Infectious HIV-1 yield was determined by a 96-well infection assay using TZM-bl indicator
cells. Briefly, 6,000 cells were seeded in 96-well plates and infected in triplicates with cell cul-
ture supernatants. Three days later, infection rates were measured using a galactosidase screen
kit (GalScreen-Applied Bioscience) according to the manufacturer’s instructions. β-galactosi-
dase activities were quantified as relative light units per second (RLU/s) using an Orion Micro-
plate Luminometer.
SERINC5 counteraction assay
To show expression of functional Nef proteins, HEK293T cells were cotransfected in 6-well
plates with increasing doses (0; 0.1; 0.5; 2.5 μg) of SERINC5 expression vectors and HIV-1
NL4-3 proviral constructs expressing different Nef proteins (2.5 μg). 40 hr post-transfection,
infectious virus yield was determined by infection of TZM-bl indicator cells for 72 hr in
triplicates.
Flow cytometry
To determine the effect of Vpr on the levels of IκBα and phosphorylation of p65 at Ser529,
HEK293T cells were transfected in 6-well plates with expression vectors for different Vpr pro-
teins (2.5 μg) coexpressing GFP via an IRES. 24 hours post-transfection cells were left
untreated or stimulated with TNFα (10 ng/ml) for 15 minutes at 37˚C before fixation with 4%
PFA for 10 minutes at 37˚C. Cells were permeabilized with ice-cold methanol for 30 minutes
on ice and washed twice before staining with AF647-coupled antibodies for IκBα (BD
#560817) or p65 phosphorylated at Ser529 (BD #558422) or the respective isotype controls.
For analysis, the APC signals of the isotype controls were subtracted and the APC signals of
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the GFP positive population of the TNFα-stimulated samples were normalized to the APC sig-
nals of the GFP positive population of the corresponding unstimulated controls. To determine
the ability of human and simian Nef proteins to downmodulate human CD3 (BD #555333),
CXCR4 (BD #555974) or CD28 (BD #559770) from the cell surface, PBMCs were transduced
with VSV-G pseudotyped HIV-1 NL4-3 expressing different Nef proteins and coexpressing
GFP via an IRES. Protein surface expression was determined 3 days post-transduction. To ana-
lyze the effects of Nef on human and colobus CD3, HEK293T cells were cotransfected with
proviral constructs for HIV-1 NL4-3 expressing different Nef proteins and coexpressing GFP
via an IRES and constructs expressing fusion proteins between the cytoplasmic part of human
or colobus CD3z and the extracellular part of CD8. CD8 surface expression (BD #555369) was
determined 40 hr post-transfection. Infection rates of SupD1 cells or PBMCs were controlled
by intracellular staining for p24 (KC57-RD1; Beckman Coulter) after fixation and permeabili-
zation of the cells using the FIX&PERM kit (Nordic MUbio) according to the manufacturer’s
instructions. Flow cytometric measurements were performed using a BD FACS Canto II flow
cytometer.
Cell cycle analysis
Jurkat cells were transduced with VSV-G pseudotyped HIV-1 CH293.1 expressing heterolo-
gous Vprs. After 48 hr, cells were fixed with 1% PFA for 20 min at RT and subsequently per-
meablized with 0.1% Triton to stain p24 (KC57-FITC; Beckman Coulter) for 45 min at 4˚C.
DNA staining was performed with propidium iodide (50 mg/ml) and 100 μg/ml RNase in
0.1% Triton for 1 hr at RT before flow cytometric analysis to determine the effect of Vpr on
cell cycle phases in infected (p24+) cells.
Apoptosis assay
HEK293T cells were transfected with pCG vectors coexpressing Vpr and eGFP. Two days post
transfection, cells were stained with Fixable Viability Stain (FVS, BD #562247) and Annexin V
(AnnV; BD #550474) and analyzed by flow cytometry. Cells were categorized as FVS+/AnnV+
(dead), FVS-/AnnV- (live) or FVS-/AnnV+ (early apoptosis).
NF-κB reporter assay in HIV-1 infected cells
To determine the effect of Vpr proteins on NF-κB activity, SupD1 cells were seeded in 96-well
plates and transduced in triplicates with VSV-G pseudotyped HIV-1 CH293.1 expressing het-
erologous Vprs. Cells were harvested at various time points post-transduction to determine
NF-κB-dependent firefly luciferase activity. Transduction efficiency was monitored by flow
cytometry. To determine the effect of multiple rounds of infection on NF-κB activation,
SupD1 cells were infected in the presence or absence of the protease inhibitor Darunavir (10
mM). NF-κB activation was measured at various time points post-transduction and superna-
tants were used to infect TZM-bl indicator cells to check whether Darunavir treatment was
efficient.
Western blot
Cells were lysed in Western blot lysis buffer (150 mM NaCl, 50 mM HEPES, 5 mM EDTA,
0.1% NP40, 500 μM Na3VO4, 500 μM NaF, pH 7.5). Cell-free virions were pelleted by centrifu-
gation of cell culture supernatants through a 20% sucrose cushion at 20,800 g for 90 min at
4˚C and lysed in Western blot lysis buffer. Lysates were mixed with Protein Sample Loading
Buffer (LI-COR) supplemented with 10% β-mercaptoethanol, heated at 95˚C for 5 min,
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separated on NuPAGE 4–12% Bis-Tris Gels (Invitrogen) and blotted onto Immobilon-FL
PVDF membranes (Merck Millipore). Proteins were stained using primary antibodies directed
against HIV-1 Env (obtained through the NIH AIDS Reagent Program, Division of AIDS,
NIAID, NIH: 16H3 mAb from Drs. Barton F. Haynes and Hua-Xin Liao) [58], p24 (Abcam
#ab9071), AU-1 (Novus Biologicals #NB600-453), β-actin (Abcam #ab8226), GAPDH (BioLe-
gend #631401), GFP (Abcam #ab290), DCAF1 (Proteintech #11612-1-AP) and Infrared Dye
labeled secondary antibodies (LI-COR IRDye). Proteins were detected using an LI-COR Odys-
sey scanner and band intensities were quantified using LI-COR Image Studio Lite Version 3.1.
qRT-PCR
Total RNA was isolated and purified from transduced PBMCs using the RNeasy Plus Mini Kit
(QIAGEN) and residual genomic DNA was removed using the DNA-free™ Kit (Life Technolo-
gies #AM1906). 150 ng of RNA were reversely transcribed using the PrimeScript RT reagent
Kit (TAKARA #RR037A) with oligo dT and random hexamer primers. To control complete
removal of genomic DNA, control samples without reverse transcriptase were included in the
reaction. Generated cDNA was subjected to quantitative real time PCR using TaqMan primer/
probe sets for human IFNB1 (Thermo Fisher Scientific #Hs01077958_s1), IFI44 (Thermo
Fisher Scientific #Hs00197427_m1) and GAPDH (Thermo Fisher Scientific #4310884E) as
control. Ct data was processed relative to the GAPDH control.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.0. Two-tailed, unpaired or paired
student’s t-test and one sample t-test were used to determine statistically significant differences
( p 0.05;  p 0.01;  p 0.001). Correlation analyses were performed using Spearman’s
non-parametric correlation test.
Supporting information
S1 Fig. Protein sequences and receptor downmodulation activity of SIVcol and SIVolc Nef.
(A) Sequence alignment of the Nef proteins analyzed in Fig 1. Dots indicate identical amino
acids. Gaps that were introduced to improve the alignment are indicated by dashes. Functional
motifs are highlighted in color (bdg., binding; AP, adaptor proteins; SH3, Src-homology 3;
PAK1/2, p21 activated kinase 1; V1H, subunit H of the vacuolar membrane ATPase). (B), (C)
PBMCs were transduced with VSV-G pseudotyped NL4-3 constructs coexpressing the indi-
cated Nef proteins and eGFP via an IRES. 72 hr post-transduction, CD28 (B) or CXCR4 (C)
surface levels were quantified by flow cytometry. Mean values of five infections ± SD are
shown (p< 0.01; p< 0.001). (D) HEK293T cells were cotransfected with HIV-1 NL4-3
IRES eGFP constructs expressing the indicated nef alleles and plasmids expressing fusion pro-
teins that consist of the extracellular and transmembrane domain of human CD8 and the
intracellular part of either human or colobus CD3z. 40 hr post transfection, CD8-CD3z surface
expression levels were analyzed by flow cytometry. Primary FACS data of one representative
experiment are shown. Numbers indicate the mean fluorescence intensities of CD8-CD3z
APC in the eGFP negative and positive populations.
(TIF)
S2 Fig. Sequences, expression, induction of apoptosis and NF-κB modulation by primate
lentiviral Vpr proteins. (A) Sequence alignment of the 32 Vpr proteins analyzed in this study.
Dots indicate identical amino acids. Gaps that were introduced to improve the alignment are
indicated by dashes. Yellow boxes highlight conserved amino acid residues in the first α-helix,
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which has previously been shown to be involved in G2 arrest, nuclear localization and virion-
packaging of Vpr. (B) Western blot analysis of HEK293T cells transfected with expression vec-
tors for the indicated AU1-tagged vpr alleles coexpressing enhanced green fluorescent protein
(eGFP) via an internal ribosomal entry site (IRES). Expression of Vpr was visualized with an
antibody against the AU1-tag. eGFP and GAPDH were detected to control for transfection
efficiencies and protein amounts, respectively. (C) Flow cytometric analysis of HEK293T cells
transfected with the indicated Vpr expression plasmids. Viability of the cells was determined
48 hr post-transfection by staining with Annexin V and Fixable Viability Stain. Mean values of
three experiments ± SEM are shown. Overexpression of the pro-apoptotic protein APOL6 [59]
served as positive control. Asterisks indicate statistically significant differences in the percent-
age of dead cells compared to the vector control (p< 0.01). (D) Correlation of TNFα- and
IKKβ-induced NF-κB activation shown in Fig 2 (green: Vprs from lentiviruses encoding vpu;
blue: Vprs from lentiviruses downmodulating CD3 via Nef; orange: SIVcol and SIVolc Vpr).
Spearman’s non-parametric correlation coefficient (r) was calculated. (E, F) COS-7 cells
(derived from African green monkeys) were cotransfected with the indicated vpr alleles, a fire-
fly luciferase reporter construct under the control of three NF-κB binding sites, and a Gaussia
luciferase construct for normalization. To activate NF-κB, cells were (E) stimulated with
TNFα or (F) cotransfected with a constitutively active mutant of IKKβ (c.a. IKKβ). Luciferase
activities were determined 40 hr post-transfection. Mean values of three independent experi-
ments in triplicates ± SEM are shown. Asterisks indicate statistically significant differences
compared to the vector control (p< 0.01; p< 0.001).
(TIF)
S3 Fig. Inhibition of IFNβ promoter activity by SIVcol and SIVolc Vpr. HEK293T cells
were cotransfected with the indicated vpr alleles, a Gaussia luciferase construct for normaliza-
tion, and a firefly luciferase reporter construct to determine IFNβ promoter activity (with wild
type or mutated NF-κB binding site). To activate the IFNβ promoter, cells were stimulated
with Sendai virus. Luciferase activities were determined 40 hr post-transfection. Mean values
of three independent experiments in triplicates ± SEM are shown.
(TIF)
S4 Fig. Infection rates of HIV-1 CH293.1 expressing heterologous vpr alleles. (A) TZM-bl
reporter cells were infected with chimeric CH293.1 viruses expressing the indicated vpr alleles.
Virus stocks were produced in HEK293T cells and pseudotyped with the glycoprotein of the
vesicular stomatitis virus (VSV-G) if indicated. Three days post infection, β-galactosidase
activity was determined. Mean values of three experiments with triplicate infections ± SEM are
shown. (B) Mean cumulative NF-κB activity of the kinetics shown in Fig 4D was calculated.
The mean values of triplicate infections ± SD are shown. Asterisks indicate significant differ-
ences compared to CH293.1 vpu- vpr- (p< 0.01; p< 0.001). (C) SupD1 cells were trans-
duced with the indicated VSV-G pseudotyped CH293.1 chimeras. 30 hr post-transduction, the
percentage of p24-expressing cells was determined by flow cytometry. Values represent infec-
tion rates of the experiment shown in Fig 4D. (D) The GAPDH and IFNβ amplification prod-
ucts of the qRT-PCR analyses shown in Fig 4E of donor B were analyzed by gel
electrophoresis. (E) PBMCs were transduced with VSV-G pseudotyped CH293.1 chimeras
expressing the indicated vpr alleles. Cells were harvested 72 hr post-transduction, and total cel-
lular RNA was isolated and reversely transcribed. IFI44 mRNA levels were determined by
quantitative RT-PCR and normalized to GAPDH mRNA. The mean values ± SEM are shown.
Asterisks indicate statistically significant differences compared to CH293.1 wild type infected
cells (p<0.05). (F) The percentage of p24-expressing cells of the experiments shown in Fig 4E
and S4E Fig was determined by flow cytometry, 72 hr post-transduction. The results of three
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donors are shown. Donors A-C in Fig 4E, S4E and S4F Fig are identical.
(TIF)
S5 Fig. Role of DCAF1 and modulation of IκBα degradation and p65 phosphorylation by
Vpr. (A) HEK293T cells were cotransfected with the indicated vpr alleles, a firefly luciferase
reporter construct under the control of three NF-κB binding sites, a Gaussia luciferase con-
struct for normalization and shRNA vectors to deplete DCAF1. Cells were stimulated with
TNFα (left panel) or cotransfected with a constitutively active mutant of IKKβ (c.a. IKKβ)
(middle panel). Luciferase activities were determined 40 hr post-transfection. Mean values of
two independent experiments performed in triplicate transfections ± SEM are shown. To con-
firm DCAF1 knockdown, Western blotting of transfected (i.e. eGFP positive cells) was per-
formed 40 hr post-transfection (right panel). GAPDH served as loading control and was used
to calculate relative DCAF1 levels. (B) HEK293T cells were transfected with plasmids coex-
pressing the indicated vpr alleles and eGFP or a dominant-negative mutant of IKKβ (d. n.
IKKβ). Cells were stimulated 24 hr post-transfection with TNFα (10 ng/ml) or left untreated.
Fifteen minutes after stimulation, cells were harvested, fixed, and permeabilized and levels of
IκBα were analyzed by flow cytometry. Primary FACS data of one representative experiment
are shown. Numbers indicate the mean fluorescence intensities of IκBα-APC in the eGFP neg-
ative and positive populations. (C) Levels of phosphorylated p65 (Ser529) were determined by
flow cytometry as described in (B). Primary FACS data of one representative experiment are
shown. Numbers indicate the mean fluorescence intensities of p65 phospho-Ser529-APC in
the eGFP negative and positive populations.
(TIF)
S6 Fig. Modulation of NF-κB- and Sp1-driven LTR activation by Vpr. (A) Nucleotide
sequence alignment of the HIV-1 NL4-3, SIVcol CM243 and SIVolc 97CI12 LTR sequences
analyzed in Fig 6A and 6B. Classical NF-κB binding sites (GGGRNNYYCC) are indicated by
blue boxes [60], extended NF-κB binding sites (RGGRNNHHYYB) including sequences
bound by RELA homodimers are highlighted in grey [61]. (B) HEK293T cells were cotrans-
fected with the indicated vpr alleles, a firefly luciferase reporter construct under the control of
the HIV-1 M LTR promoter, and a Gaussia luciferase construct for normalization. The LTR
promoter was either intact (wt) or lacked functional NF-κB or Sp1 binding sites (NF-κB mut.
and Sp1 mut., respectively). Cells were stimulated by cotransfection of a constitutively active
mutant of IKKβ (c.a. IKKβ) or Sp1. Luciferase activities were determined 40 hr post-transfec-
tion. Mean values of three independent experiments in triplicates ± SEM are shown (p<0.05;
p< 0.01).
(TIF)
S7 Fig. Vpr in trans and in cis complementation of HIV-1 CH293.1 vpu- vpr-. (A)
HEK293T cells were transfected with the indicated infectious molecular clones. The indicated
vpr alleles were either encoded in the viral genome (in cis) or expressed from a pCG expression
vector (in trans) coexpressing eGFP. If Vpr was expressed in cis, a vector expressing only eGFP
was cotransfected. 40 hr post-transfection, cells and supernatants were harvested and Western
blotting was performed to detect AU1-tagged Vpr and Gag. eGFP and β-actin were detected to
control for transfection efficiencies and protein loading, respectively and served as purity con-
trols in the supernatant. (B) SupD1 cells were transduced with the indicated VSV-G pseudo-
typed CH293.1 viruses expressing Vpr in cis or in trans. 30 hr post-transduction, the
percentage of p24-expressing cells was determined by flow cytometry. Values represent infec-
tion rates of the experiment shown in Fig 7. (C) Mean cumulative NF-κB activity of the kinet-
ics shown in Fig 7 was calculated. The mean values of triplicate infections ± SD are shown.
Modulation of NF-κB activation by lentiviral Vpr proteins
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006598 August 31, 2017 23 / 28
Asterisks indicate significant differences compared to CH293.1 vpu- vpr- (p<0.05;
p< 0.01; p< 0.001). (D) SupD1 cells were transduced with the indicated VSV-G pseudo-
typed CH293.1 mutants in the presence or absence of the protease inhibitor Darunavir (100
nM). As a reporter for NF-κB activation, firefly luciferase activities in the cells were deter-
mined 48 and 72 hr after transduction. The mean values of triplicate infections ± SD are
shown. (E) Infection rates of the cells described in (D) were determined 48 hr after infection
by p24 staining in permeabilized cells, followed by FACS analysis. (F) Supernatants of the
SupD1 cells described in (D) were harvested 48 and 72 hr after infection and infectious virus
yield was determined by infection of TZM-bl cells for 72 h in the presence of Darunavir (100
nM). In (D), (E) and (F), the results of the same representative experiment are shown.
(TIF)
S1 Table. Oligonucleotides used to generate HIV-1 NL4-3 IRES eGFP constructs express-
ing different nef alleles.
(DOCX)
S2 Table. Oligonucleotides used to generate pCG IRES eGFP constructs expressing differ-
ent vpr alleles.
(DOCX)
S3 Table. Oligonucleotides used to generate CD8-CD3z fusion constructs.
(DOCX)
S4 Table. Oligonucleotides used to generate pGL3 LTR firefly luciferase reporter con-
structs.
(DOCX)
S5 Table. Oligonucleotides used to generate CH293.1 proviruses expressing heterologous
vpr alleles.
(DOCX)
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